Status:
COMPLETED
Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment
Lead Sponsor:
Nourhan M.Aly
Collaborating Sponsors:
Alexandria University
Conditions:
Dental Anxiety
Eligibility:
All Genders
4-6 years
Phase:
PHASE2
Brief Summary
The aim of the study is to evaluate the effect of nebulized Midazolam, Dexmedetomidine, and their combination as procedural, moderate sedative agents in preschoolers undergoing dental treatment.
Detailed Description
Dental anxiety and fear related behaviors are global problems in Pediatric Dentistry. Preschoolers represent a dental behavior management problem and there is always a debate over the best behavioral ...
Eligibility Criteria
Inclusion
- Age range 4-6 years
- Frankl scale score 2.
- ASA I or II physical status.
- Dental intervention under local anesthesia not requiring more than 30 minutes.
- No previous dental experience.
- Parent/guardian"s written consent.
Exclusion
- Dental treatment indicated under general anesthesia.
- Presence of facial deformities.
- History of neurological or cognitive alterations.
- Mouth breathers.
Key Trial Info
Start Date :
November 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2019
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03827408
Start Date
November 27 2017
End Date
December 22 2019
Last Update
January 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Alexandria University
Alexandria, Egypt, 21512